The omega-3 index: Clinical utility for therapeutic intervention

Current Cardiology Reports

Volumn 12, Issue 6, 2010, Pages 503-508

  Harris, William S ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Docosahexaenoic acid (DHA); Eicosapentaenoic acid (EPA); Omega 3 Index

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; LONG CHAIN FATTY ACID; OMEGA 3 FATTY ACID;

CARDIOVASCULAR RISK; CLINICAL PRACTICE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DISEASE MARKER; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG RESEARCH; EVIDENCE BASED MEDICINE; FATTY ACID BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; METABOLIC SYNDROME X; RECOMMENDED DRUG DOSE; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SENSITIVITY ANALYSIS; VALIDATION PROCESS;

BIOLOGICAL MARKERS; DEATH, SUDDEN, CARDIAC; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; ERYTHROCYTES; FATTY ACIDS, OMEGA-3; HEALTH STATUS; HEALTH STATUS INDICATORS; HUMANS; RISK FACTORS; UNITED STATES;

EID: 77958502858     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-010-0141-6     Document Type: Review

References (29)

1. WS Harris C von Schacky 2004 The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med 39 212 220 1:CAS:528: DC%2BD2cXltVCisL4%3D 10.1016/j.ypmed.2004.02.030 15208005 (Pubitemid 38797975)
2. MA Hlatky P Greenland DK Arnett, et al. 2009 Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association Circulation 119 2408 2416 10.1161/CIRCULATIONAHA.109.192278 19364974 This important paper provides a roadmap and rationale for the evaluation and validation of new markers for CHD
3. AB Hill 1965 The environment and disease: association or causation? Proc R Soc Med 58 295 300 1:STN:280:DyaF2M%2FovVCmsw%3D%3D 14283879
4. WS Harris 2009 The omega-3 index: from biomarker to risk marker to risk factor Curr Atheroscler Rep 11 411 417 1:CAS:528:DC%2BC3cXhtFersrrL 10.1007/s11883-009-0062-2 19852881
5. DS Siscovick TE Raghunathan I King, et al. 1995 Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest J Am Med Assoc 274 1363 1367 1:CAS:528:DyaK2MXpsl2ksL0%3D 10.1001/jama.274.17.1363
6. CM Albert H Campos MJ Stampfer, et al. 2002 Blood levels of long-chain n-3 fatty acids and the risk of sudden death N Engl J Med 346 1113 1118 1:CAS:528:DC%2BD38Xislamtr8%3D 10.1056/NEJMoa012918 11948270 (Pubitemid 34984601)
7. RC Block WS Harris KJ Reid, et al. 2007 EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls Atherosclerosis 197 821 828 10.1016/j.atherosclerosis.2007.07.042 17875307
8. K Hamazaki Y Terashima M Itomura, et al. 2009 The relationship between n-3 long-chain polyunsaturated fatty acids and pulse wave velocity in diabetic and non-diabetic patients under long-term hemodialysis. A horizontal study Clin Nephrol 71 508 513 1:CAS:528:DC%2BD1MXmsFKmsrs%3D 19473610
9. M Itomura S Fujioka K Hamazaki, et al. 2008 Factors influencing EPA+DHA levels in red blood cells in Japan In Vivo 22 131 135 18396795
10. T Ogura H Takada M Okuno, et al. 2010 Fatty acid composition of plasma, erythrocytes and adipose: their correlations and effects of age and sex Lipids 45 137 144 1:CAS:528:DC%2BC3cXhs1amuro%3D 10.1007/s11745-010-3386-3 20094809
11. A Sekikawa JD Curb H Ueshima A El Saed, et al. 2008 Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a cross-sectional study J Am Coll Cardiol 52 417 424 1:CAS:528: DC%2BD1cXpt1Grs7c%3D 10.1016/j.jacc.2008.03.047 18672160 (Pubitemid 352043837)
12. WS Harris 2008 The omega-3 index as a risk factor for coronary heart disease Am J Clin Nutr 87 1997S 2002S 1:CAS:528:DC%2BD1cXnslajs7g%3D 18541601
13. Y Park J Lim J Lee SG Kim 2009 Erythrocyte fatty acid profiles can predict acute non-fatal myocardial infarction Br J Nutr 102 1355 1361 1:CAS:528:DC%2BD1MXhsVyrtL3M 10.1017/S0007114509990298 19505347
14. M Yokoyama H Origasa M Matsuzaki, et al. 2007 Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis Lancet 369 1090 1098 1:CAS:528:DC%2BD2sXjs1Ohtro%3D 10.1016/S0140-6736(07)60527-3 17398308 (Pubitemid 46483662)
15. GISSI-HF investigators L Tavazzi AP Maggioni, et al. 2008 Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial Lancet 372 1223 1230 10.1016/S0140-6736(08)61239-8 18757090
16. R Marchioli F Barzi E Bomba, et al. 2002 Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione Circulation 105 1897 1903 1:CAS:528:DC%2BD38XktFajtbc%3D 10.1161/01.CIR.0000014682.14181.F2 11997274 (Pubitemid 34437615)
17. D Di Stasi R Bernasconi R Marchioli, et al. 2004 Early modifications of fatty acid composition in plasma phospholipids, platelets and mononucleates of healthy volunteers after low doses of n-3 polyunsaturated fatty acids Eur J Clin Pharmacol 60 183 190 10.1007/s00228-004-0758-8 15069592 (Pubitemid 38757129)
18. RG Metcalf LG Cleland RA Gibson, et al. 2010 Relation between blood and atrial fatty acids in patients undergoing cardiac bypass surgery Am J Clin Nutr 91 528 534 1:CAS:528:DC%2BC3cXisFyntLg%3D 10.3945/ajcn.2009.28302 20089730 RBC EPA+DHA levels were shown to correlate highly with human myocardial EPA+DHA content, indicating that the former is a valid surrogate marker for the latter
19. MK Larson JH Ashmore KA Harris, et al. 2008 Effects of omega-3 acid ethyl esters and aspirin, alone and in combination, on platelet function in healthy subjects Thromb Haemost 100 634 641 1:CAS:528:DC%2BD1cXhtlOgtL3L 18841286
20. RM Carney KE Freedland EH Rubin, et al. 2009 Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial JAMA 302 1651 1657 1:CAS:528:DC%2BD1MXhtlams7nN 10.1001/jama.2009.1487 19843899
21. WS Harris SL Lemke SN Hansen, et al. 2008 Stearidonic acid-enriched soybean oil increased the omega-3 index, an emerging cardiovascular risk marker Lipids 43 805 811 1:CAS:528:DC%2BD1cXhtVOntL3F 10.1007/s11745-008-3215-0 18683001
22. RC Block WS Harris JV Pottala 2008 Determinants of blood cell omega-3 fatty acid content Open Biomark J 1 1 6 1:CAS:528:DC%2BD1MXhtFaqu74%3D 10.2174/1875318300801010001 19953197
23. MB Katan JP Deslypere AP van Birgelen, et al. 1997 Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study J Lipid Res 38 2012 2022 1:CAS:528:DyaK2sXntFCntbY%3D 9374124
24. WS Harris RM Thomas 2009 Biological variability of blood omega-3 biomarkers Clin Biochem 43 338 340 10.1016/j.clinbiochem.2009.08.016 19733159 The within-person stability of the Omega-3 Index, total plasma, and plasma phospholipid EPA+DHA was assessed in 20 volunteers tested weekly for 6 weeks. The variability of the Omega-3 Index was about one third of that of the other two markers
25. R Farzaneh-Far J Lin ES Epel, et al. 2010 Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease JAMA 303 250 257 1:CAS:528:DC%2BC3cXptFShsA%3D%3D 10.1001/jama.2009.2008 20085953 This is the first study to describe an inverse association between blood levels of EPA+DHA and the rate of "cellular aging." The latter was assessed by measuring the change in leukocyte telomere length in over 600 patients with stable CHD over a 5-year period of time
26. S Ali SK Garg BE Cohen, et al. 2009 Association between omega-3 fatty acids and depressive symptoms among patients with established coronary artery disease: data from the Heart and Soul Study Psychother Psychosom 78 125 127 10.1159/000203118 19223688
27. H Aarsetoy V Ponitz OB Nilsen, et al. 2008 Low levels of cellular omega-3 increase the risk of ventricular fibrillation during the acute ischaemic phase of a myocardial infarction Resuscitation 78 258 264 1:CAS:528: DC%2BD1cXpt1GqsLw%3D 10.1016/j.resuscitation.2008.04.007 18556107
28. Kohler A, Bittner D, Low A, von Schacky C: Effects of a convenience drink fortified with n-3 fatty acids on the n-3 index. Br J Nutr 2010 Apr 27:1-8 [Epub ahead of print].
29. HO Bang J Dyerberg 1980 Lipid metabolism and ischemic heart disease in Greenland eskimos Adv Nutr Res 3 1 22 1:CAS:528:DyaL3MXivFajsQ%3D%3D